Login
$KYTX
$5.63 +$0.36 (6.83%) Close

Company Executives

$KYTX Management Team

Mr. Warner Biddle

Chief Executive Officer

Director

Age 58
Compensation $14.99M USD
Sex Male

Dr. Naji Gehchan

Chief Medical and Development Officer

Age 43
Compensation -
Sex Male

Mr. Dan Maziasz

Chief Business Officer

Age -
Compensation -
Sex Male

Ms. Cara Bauer

Chief Human Resources Officer

Age -
Compensation -
Sex Female

Ms. Christi Shaw

Executive Chairman of the Board

Age 58
Compensation $365.7K USD
Sex Female

Dr. Marc Grasso

Chief Financial Officer

Age 53
Compensation -
Sex Male

Ms. Tracy Rossin

Senior Vice President - Corporate Affairs

Communications and Investor Relations

Age 47
Compensation -
Sex Female

Mr. Mayo Pujols

Chief Technology Officer

Age 56
Compensation -
Sex Male
Directors
8
serving now
Independent
6 of 6
stated in the proxy; 2 not stated
Average tenure
3.4 years
from year joined
CEO also chairs the board
No
Christi Shaw
Director Age On board Independent Committees Other public boards 2025 pay Source
Ian Clark
65 2021
5 years
Independent
Compensation Committee Nominating and Corporate Governance Committee · Chair
None stated $259,952
Christi Shaw
59 2024
2 years
Not stated None stated Beam Therapeutics Inc. $319,892
Warner Biddle
59 2024
2 years
Not stated None stated None stated Paid as CEO
Mert Aktar
47 2024
2 years
Independent
Compensation Committee Audit Committee
None stated $232,452
Andrew Miller, Ph.D.
44 2026
0 years
Independent
Audit Committee
None stated Not stated
Beth Seidenberg, M.D.
69 2018
8 years
Independent
Compensation Committee · Chair
Vera Therapeutics, Inc., Sagimet Biosciences, Inc. $242,452
Fred E. Cohen, M.D., D.Phil.
69 2018
8 years
Independent
Science and Technology Committee · Chair
CareDx, Inc., Intellia Therapeutics, Inc. $237,452
Sravan Emany
48 2026
0 years
Independent
Audit Committee · Chair
Assertio Holdings, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 13, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support